Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
about
HIV and tuberculosis--science and implementation to turn the tide and reduce deathsAssessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic reviewHIV-Associated TB in An Giang Province, Vietnam, 2001–2004: Epidemiology and TB Treatment OutcomesNational policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and LinksAssessing the accessibility of HIV care packages among tuberculosis patients in the Northwest Region, Cameroon.EFFECT OF TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS ON FAECAL CARRIAGE RATES OF RESISTANT ISOLATES OF ESCHERICHIA COLI IN HIV-INFECTED ADULT PATIENTS IN LAGOSGenital tuberculosis as the cause of tuboovarian abscess in an immunosuppressed patient.Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.Treatment Options for HIV-Associated Tuberculosis.Assessing tuberculosis case fatality ratio: a meta-analysis.Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV.Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006-2013).Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy.Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis.Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.Potentially Modifiable Factors Associated with Death of Infants and Children with Severe Pneumonia Routinely Managed in District Hospitals in Malawi.What has Karonga taught us? Tuberculosis studied over three decades.Epidemiology of Respiratory Disease in Malawi.Epidemiology of Tuberculosis in MalawiEpidemiology of HIV/AIDS in adults in MalawiIndependent predictors of tuberculosis mortality in a high HIV prevalence setting: a retrospective cohort study.Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study.The development of health policy in Malawi: the influence of context, evidence and links in the creation of a national policy for cotrimoxazole prophylaxisEffect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in TanzaniaRole of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial.Causes of death in HIV-infected persons who have tuberculosis, Thailand.Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.Scale-up of ART in Malawi has reduced case notification rates in HIV-positive and HIV-negative tuberculosis.EFFECT OF TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS ON FEACAL CARRIAGE RATES OF RESISTANT ISOLATES OF ESCHERICHIA COLI IN HIV-INFECTED ADULT PATIENTS IN LAGOS.
P2860
Q26824501-FC8C1F8B-C0BB-44E9-A9FA-CFFFE3AB58DBQ28084544-9D91B411-EF6B-44BB-B48D-760929CD2F55Q30047301-1C921C3B-64AE-4BFC-8055-FC5BB72F90B4Q30501533-3E63BA4A-65FE-4DC9-B80A-0BB76220D9F5Q33540310-DEDB829D-D926-4A4F-8C3C-7DC13CAB490BQ33623400-3EF63DC7-77CF-485D-8281-4C6A14305DC4Q33712864-9F7E8A8B-540D-4639-89DD-E9B7772B7014Q33793347-B86EC2D4-19F2-4CD5-8F30-B889F164ECCDQ33813097-BF985B1D-4C5D-44F6-8D0A-19D2D2176041Q33954598-97506D7F-25DC-4F89-A9D5-1C5881DC83E2Q33973050-42FDD93A-D86F-46EE-B0F0-21DF757C3824Q34455442-5D9436ED-D73C-4C08-AF39-148387CFB216Q34704432-13AACA46-99F5-4EB2-B65F-0D37F20C6420Q34734600-9334EF02-77C7-469B-BBBD-572617928D72Q35207311-571F1331-FA0E-4F92-BEF1-C6EF54CFF45FQ35594099-EC74A45E-9651-4BF5-A88D-ED8CD2DBCCC9Q35734934-C6533C8D-44BE-4983-9C53-20D70EC3B55BQ35737870-D0F78DEC-E797-4868-B1F7-A14AFAC39F40Q35937990-3C048837-BABD-459A-B766-8DE0776B163FQ35937995-25573DDC-C12D-4987-8772-ACB29E949C7AQ35938001-8246A9C2-0AB6-4182-9D34-98D25A4CE3BAQ36131547-FCB877EF-019E-4734-AFE7-26665798C260Q36379384-A7E4F493-795B-48AC-A0EA-043A46F29AAEQ36657522-9EA6995D-588A-407B-8C9A-FAF8D70DFD2DQ36982435-1E930EB2-2FA9-4C91-8886-EA9E18AC633EQ37131431-9282F67C-F5CB-4689-BD4B-FE51BBC0C94DQ37133305-5D3021E6-EE07-4BBF-82A6-F13C822BDD11Q37265947-3896DF74-4347-4DFB-9FFE-BAF0A4ED4636Q37524217-BD224F66-5393-491C-89D5-274877412BBAQ37698989-422598D6-5725-4D6A-9CBB-01A47942942D
P2860
Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cotrimoxazole prophylaxis redu ...... s in Karonga District, Malawi.
@en
Cotrimoxazole prophylaxis redu ...... s in Karonga District, Malawi.
@nl
type
label
Cotrimoxazole prophylaxis redu ...... s in Karonga District, Malawi.
@en
Cotrimoxazole prophylaxis redu ...... s in Karonga District, Malawi.
@nl
prefLabel
Cotrimoxazole prophylaxis redu ...... s in Karonga District, Malawi.
@en
Cotrimoxazole prophylaxis redu ...... s in Karonga District, Malawi.
@nl
P2093
P921
P1476
Cotrimoxazole prophylaxis redu ...... s in Karonga District, Malawi.
@en
P2093
Amelia C Crampin
Anthony D Harries
Frank B D Mwaungulu
Huxley Kanyongoloka
Judith R Glynn
Paul E M Fine
Sian Floyd
Simon Malema
Simplex Kasimba
P304
P407
P577
2004-05-01T00:00:00Z